- Previous Close
5.57 - Open
5.75 - Bid 5.58 x --
- Ask 5.59 x --
- Day's Range
5.54 - 5.62 - 52 Week Range
4.28 - 6.32 - Volume
6,824,000 - Avg. Volume
26,429,828 - Market Cap (intraday)
9.643B - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
22.32 - EPS (TTM)
0.25 - Earnings Date --
- Forward Dividend & Yield 0.08 (1.44%)
- Ex-Dividend Date Nov 18, 2024
- 1y Target Est
--
C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. The company engages in the research, development, production, and investment for medical device in the pharmaceutical industry. It offers medicines, medical devices, Chinese herbal medicines, health care products, hospital sales, and commercial wholesale, retail chain; terminal distribution; warehousing logistics; and supply chain value-added services. In addition, the company provides medical care and health products for medical care, elderly care, and rehabilitation; operates and manages medical institutions. The company was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1999 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. is a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company.
www.cqphar.com14,485
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 000950.SZ
View MorePerformance Overview: 000950.SZ
Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000950.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000950.SZ
View MoreValuation Measures
Market Cap
9.63B
Enterprise Value
25.54B
Trailing P/E
22.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.12
Price/Book (mrq)
0.84
Enterprise Value/Revenue
0.31
Enterprise Value/EBITDA
13.18
Financial Highlights
Profitability and Income Statement
Profit Margin
0.53%
Return on Assets (ttm)
1.47%
Return on Equity (ttm)
3.58%
Revenue (ttm)
81.43B
Net Income Avi to Common (ttm)
429.57M
Diluted EPS (ttm)
0.25
Balance Sheet and Cash Flow
Total Cash (mrq)
6.7B
Total Debt/Equity (mrq)
156.01%
Levered Free Cash Flow (ttm)
-100.91M